QL2302 / Qilu Pharma - LARVOL DELTA

A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects (clinicaltrials.gov) - P1 | N=178 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P1 trial

Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma (clinicaltrials.gov) - P3 | N=636 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P3 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases